You just read:

The Lancet Publishes First Head-to-Head Study of CIMZIA® (certolizumab pegol) and Humira® (adalimumab) in Bio-Naïve Rheumatoid Arthritis Patients

News provided by

UCB

Nov 15, 2016, 11:00 ET